Promoting the use of evidence in health policymaking in the ECOWAS region: the development and contextualization of an evidence-based policymaking guidance.
Evidence
Guidance
Health
Policymaking
West Africa
Journal
Globalization and health
ISSN: 1744-8603
Titre abrégé: Global Health
Pays: England
ID NLM: 101245734
Informations de publication
Date de publication:
06 08 2020
06 08 2020
Historique:
received:
16
05
2020
accepted:
27
07
2020
entrez:
9
8
2020
pubmed:
9
8
2020
medline:
10
4
2021
Statut:
epublish
Résumé
The Economic Commission of the West African States (ECOWAS), through her specialised health Institution, the West African Health Organization (WAHO) is supporting Members States to improve health outcomes in West Africa. There is a global recognition that evidence-based health policies are vital towards achieving continued improvement in health outcomes. The need to have a tool that will provide systematic guide on the use of evidence in policymaking necessitated the production of the evidence-based policy-making (EBPM) Guidance. Google search was performed to identify existing guidance on EBPM. Lessons were drawn from the review of identified guidance documents. Consultation, interaction and interviews were held with policymakers from the 15 West African countries during WAHO organized regional meetings in Senegal, Nigeria, and Burkina Faso. The purpose was to elicit their views on the strategies to promote the use of evidence in policymaking to be included in the EBPM Guidance. A regional Guidance Validation Meeting for West African policymakers was thereafter convened by WAHO to review findings from review of existing guidance documents and validate the EBPM Guidance. Out of the 250 publications screened, six publications fulfilled the study inclusion criteria and were reviewed. Among the important issues highlighted include: what evidence informed decision-making is; different types of research methods, designs and approaches, and how to judge the quality of research. The identified main target end users of the EBPM Guidance are policy/decision makers in the West African sub-region, at local, sub-national, national and regional levels. Among the key recommendations included in the EBPM Guidance include: properly defining/refining policy problem; reviewing contextual issues; initiating policy priority setting; considering political acceptability of policy; commissioning research; use of rapid response services, use of policy advisory/technical/steering committees; and use of policy briefs and policy dialogue. The EBPM Guidance is one of the emerging tools that can enhance the understanding of evidence to policy process. The strategies to facilitate the use of evidence in policymaking outlined in the Guidance, can be adapted to local context, and incorporated validated approaches that can be used to promote evidence-to-policy-to-practice process in West Africa.
Sections du résumé
BACKGROUND
The Economic Commission of the West African States (ECOWAS), through her specialised health Institution, the West African Health Organization (WAHO) is supporting Members States to improve health outcomes in West Africa. There is a global recognition that evidence-based health policies are vital towards achieving continued improvement in health outcomes. The need to have a tool that will provide systematic guide on the use of evidence in policymaking necessitated the production of the evidence-based policy-making (EBPM) Guidance.
METHODS
Google search was performed to identify existing guidance on EBPM. Lessons were drawn from the review of identified guidance documents. Consultation, interaction and interviews were held with policymakers from the 15 West African countries during WAHO organized regional meetings in Senegal, Nigeria, and Burkina Faso. The purpose was to elicit their views on the strategies to promote the use of evidence in policymaking to be included in the EBPM Guidance. A regional Guidance Validation Meeting for West African policymakers was thereafter convened by WAHO to review findings from review of existing guidance documents and validate the EBPM Guidance.
RESULTS
Out of the 250 publications screened, six publications fulfilled the study inclusion criteria and were reviewed. Among the important issues highlighted include: what evidence informed decision-making is; different types of research methods, designs and approaches, and how to judge the quality of research. The identified main target end users of the EBPM Guidance are policy/decision makers in the West African sub-region, at local, sub-national, national and regional levels. Among the key recommendations included in the EBPM Guidance include: properly defining/refining policy problem; reviewing contextual issues; initiating policy priority setting; considering political acceptability of policy; commissioning research; use of rapid response services, use of policy advisory/technical/steering committees; and use of policy briefs and policy dialogue.
CONCLUSION
The EBPM Guidance is one of the emerging tools that can enhance the understanding of evidence to policy process. The strategies to facilitate the use of evidence in policymaking outlined in the Guidance, can be adapted to local context, and incorporated validated approaches that can be used to promote evidence-to-policy-to-practice process in West Africa.
Identifiants
pubmed: 32762759
doi: 10.1186/s12992-020-00605-z
pii: 10.1186/s12992-020-00605-z
pmc: PMC7409627
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
73Références
Bull World Health Organ. 2015 Jan 1;93(1):47-51
pubmed: 25558107
J Public Health Policy. 2012 Nov;33(4):423-9
pubmed: 22913936
Health Promot Perspect. 2015 Jul 07;5(2):104-15
pubmed: 26290826
Nature. 2018 Jun;558(7710):361-364
pubmed: 29925978
J Epidemiol Community Health. 2005 Aug;59(8):632-7
pubmed: 16020638
Int J Health Policy Manag. 2017 Feb 04;6(10):561-571
pubmed: 28949472
Afr Health Sci. 2017 Sep;17(3):700-711
pubmed: 29085397
Health Promot Int. 2005 Jun;20(2):187-93
pubmed: 15722364
Glob Public Health. 2012;7(7):750-65
pubmed: 22394290
Int J Ment Health Syst. 2015 Jul 08;9:27
pubmed: 26155307
Health Res Policy Syst. 2009 Dec 16;7 Suppl 1:S13
pubmed: 20018103
BMJ. 2012 Feb 27;344:e1316
pubmed: 22371864
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11811-11816
pubmed: 27698126
Cost Eff Resour Alloc. 2018 Nov 9;16(Suppl 1):52
pubmed: 30455611
BMC Health Serv Res. 2016 Jul 18;16 Suppl 4:222
pubmed: 27454448
Health Res Policy Syst. 2017 Jul 12;15(Suppl 1):53
pubmed: 28722551
PLoS One. 2013 Oct 30;8(10):e77404
pubmed: 24204823
Health Res Policy Syst. 2017 Jul 12;15(Suppl 1):50
pubmed: 28722563
Implement Sci. 2014 Sep 10;9:114
pubmed: 25208522
Prev Med. 2017 Dec;105:397-403
pubmed: 28865810
PLoS Med. 2012;9(3):e1001187
pubmed: 22448147
Vaccine. 2018 Sep 5;36(37):5536-5543
pubmed: 30076103
BMC Health Serv Res. 2016 Jul 18;16 Suppl 4:216
pubmed: 27454165
Annu Rev Public Health. 2006;27:195-233
pubmed: 16533115
Int J Health Policy Manag. 2018 Sep 08;7(12):1145-1147
pubmed: 30709090
PLoS Med. 2012;9(3):e1001186
pubmed: 22427746
PLoS One. 2017 Jan 5;12(1):e0168842
pubmed: 28056098
Lancet. 2004 Sep 4-10;364(9437):900-6
pubmed: 15351199
Health Policy. 1995 Apr-Jun;32(1-3):47-77
pubmed: 10172580
Transl Behav Med. 2017 Sep;7(3):486-491
pubmed: 28397159
Health Res Policy Syst. 2017 Jul 12;15(Suppl 1):54
pubmed: 28722556
Health Res Policy Syst. 2015 May 30;13:27
pubmed: 26022699
BMC Health Serv Res. 2016 Jul 18;16 Suppl 4:218
pubmed: 27454907
BMJ Glob Health. 2018 Jan 29;3(1):e000537
pubmed: 29564156
Int J Health Policy Manag. 2015 May 20;4(9):599-610
pubmed: 26340489
Vaccine. 2015 Jun 9;33(25):2858-61
pubmed: 25900134
J Pers Soc Psychol. 2003 Nov;85(5):808-22
pubmed: 14599246
Health Care Anal. 2007 Sep;15(3):159-67
pubmed: 17922194
Implement Sci. 2015 Sep 28;10:135
pubmed: 26416206
Health Res Policy Syst. 2009 Dec 16;7 Suppl 1:S1
pubmed: 20018099
Global Health. 2018 Nov 6;14(1):104
pubmed: 30400931
Vaccine. 2012 Mar 28;30(15):2588-93
pubmed: 22330125
Health Res Policy Syst. 2017 Jul 12;15(Suppl 1):55
pubmed: 28722555
PLoS Med. 2005 Jul;2(7):e166
pubmed: 15913387
Int J Health Policy Manag. 2017 Apr 10;7(1):15-26
pubmed: 29325399
Health Policy Plan. 2003 Mar;18(1):31-46
pubmed: 12582106
Int J Health Policy Manag. 2015 Feb 04;4(3):161-8
pubmed: 25774373
Prev Med. 2018 Sep;114:95-101
pubmed: 29940293
PLoS Med. 2012;9(3):e1001185
pubmed: 22412356
Int J Health Policy Manag. 2016 Oct 08;6(6):309-316
pubmed: 28812823
J Clin Epidemiol. 2011 Jan;64(1):11-20
pubmed: 20189767